Wire · opportunities
Abbott secures US FDA approval for Aveir VR Mini ventricular leadless pacemaker
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 17 September 2026 · Fusion42 review
Abbott received FDA approval for the Aveir VR Mini ventricular leadless pacemaker, featuring a smaller size and extended implant options for patients with slow heart rhythms. It is part of Abbott's dual-chamber leadless pacing system, which uses implant-to-implant communication technology to synchronise heartbeats.
This Wire brief sits within Fusion42's coverage of Medtech, and 2 sources have reported it between 15 Sep 2026 and 17 Sep 2026.
◆ ◆ The Wire takeaway
You have a new path to treat slow heart rhythms without chest scars or leads to manage. Abbott’s smaller leadless pacemaker reshapes what patient options and procedures can look like in cardiac care.
◆ Coverage
2 sources · first reported 15 Sep 2026 · latest 17 Sep 2026
◆ Related on Wire
◆ Topics